February 26, 2018
Cambridge Medical Robotics announces company name change to CMR Surgical
February 26, 2018
Cambridge Medical Robotics announces company name change to CMR Surgical

Cambridge Medical Robotics (CMR), the British company developing the next-generation surgical robot, has announced its name has changed to CMR Surgical.

CMR Surgical

Patrick Pordage

Head of Marketing

T: +44 (0) 1223 755 388

The new name reflects the company’s ambitious vision to transform surgery as it plans for the launch of its next-generation universal surgical robotic system, Versius, later in the year. Versius, a surgical robot, is designed to meet the complex requirements of laparoscopic surgery. It is inspired by the human arm and has remarkable dexterity, flexibility and reach, enabling a new paradigm in surgical experience – driving CMR Surgical’ s vision in making minimal access surgery available to all.

Martin Frost, CMR Surgical’s Chief Executive Officer, said: “We are excited at the opportunity to become a game-changer in surgery and our company name needs to reflect the scale of our ambition. 2018 will be an important milestone for the company as we move from development to commercialisation and move a step closer to realising our ambition of making minimal access surgery accessible to more patients worldwide.”

In the run up to launch, CMR Surgical has more than doubled in size in the past year. In only four years since incorporation, the company now employs over 170 people and expects to continue its significant growth following the recently announced agreement to develop a new 42,000 sq. ft. global headquarters on the outskirts of the city.

ENDS

About CMR Surgical
CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius®, for minimal access surgery. The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year. Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit www.cmrsurgical.com

About Versius, the CMR Surgical robotic system
Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily into the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort. Intended to be used across a range of surgical specialties, the versatility and portability of Versius, enabled by a unique and patented four-axis wrist joint, expands the potential for higher utilisation. The versatility of the system and compelling commercial model allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.

1 Industry Forecast, Accuray Research